Literature DB >> 1556044

Epidemiology of bladder cancer.

D T Silverman1, P Hartge, A S Morrison, S S Devesa.   

Abstract

Approximately 49,000 persons in the United States develop bladder cancer each year, and about 9700 die of it. White men face a lifetime risk of almost 3%; white women and black men face a risk of about 1%, and black women, about 0.5%. Cigarette smoking is accepted widely as a cause of bladder cancer. Smoking accounts for about half of bladder cancer diagnosed among men and about one third of that among women. Moderate to heavy smokers typically show a two to five fold risk of bladder cancer, compared with persons who never smoked. When cigarette smokers quit smoking, their bladder cancer risk falls measurably within 2 to 4 years, but probably does not continue to decline with increasing years since quitting and does not appear to return to the baseline level of nonsmokers. Occupational exposure to certain aromatic amines causes human bladder cancer. Clear evidence of bladder cancer risk also is apparent for a small number of occupational groups: dye workers, rubber workers, leather workers, painters, truck drivers, and aluminum workers. Many other occupational groups have been reported to have increased bladder cancer risk, but evidence for these is not as strong. Coffee drinking has been studied extensively as a potential risk factor, but the inconsistency of the observed associations suggests that the relationship is either quite weak, noncausal, or dependent in a complex way on unmeasured factors. Artificial sweeteners confer little or no excess bladder cancer risk. Alcohol consumption apparently does not affect risk either. Consumption of fruits, vegetables, and foods high in vitamin A have been suggested as possible protective factors; consumption of high-fat foods, pork, and beef have been suggested as possible risk factors. Further epidemiologic research is needed to elucidate the role of diet in human bladder carcinogenesis. Less common risk factors for bladder cancer include ionizing radiation, cyclophosphamide use, and abuse of phenacetin-containing analgesics. Schistosomiasis infection may contribute substantially to the bladder cancer burden in Egypt and elsewhere, though not in the United States.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1556044

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  50 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

2.  Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort.

Authors:  Jiachen Zhou; Scott Smith; Edward Giovannucci; Dominique S Michaud
Journal:  Am J Epidemiol       Date:  2012-02-21       Impact factor: 4.897

3.  Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

Authors:  Alan R Schned; Petra Lenz; Lee E Moore; Alison Johnson; Michael Jones; Masatoshi Kida; Debra T Silverman; Molly Schwenn; Karl T Kelsey; Angeline S Andrew; Dalsu Baris; Margaret R Karagas
Journal:  ISRN Pathol       Date:  2012

Review 4.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

5.  The contribution of urethrocystoscopy to evaluation of lower urinary tract dysfunction in women.

Authors:  G W Cundiff; A E Bent
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

6.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

7.  Fluid intake and risk of bladder cancer in the Nurses' Health Studies.

Authors:  Jiachen Zhou; Karl T Kelsey; Edward Giovannucci; Dominique S Michaud
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

8.  Screening for bladder cancer: the best opportunity to reduce mortality.

Authors:  Yves Fradet
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 9.  Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.

Authors:  Kazuki Moro; Masayuki Nagahashi; Rajesh Ramanathan; Kazuaki Takabe; Toshifumi Wakai
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

Review 10.  Lifestyle issues and genitourinary tumours.

Authors:  Frank Sommer; Theo Klotz; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2003-12-12       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.